WASHINGTON, June 11 -- Food and Drug Administration has issued a notice called: Reauthorization of the Medical Device User Fee Amendments; Public Meeting; Request for Comments.

The notice was published in the Federal Register on June 11 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, the Agency, or we) is hosting a hybrid public meeting entitled "Medical Device User Fee Amendments." The purpose of the public meeting is to discuss proposed recommendations for the reauthorization of the Medical Device User Fee Amendments (MDUFA) for fiscal years (FYs) 2028 through 2032. MDUFA authorizes FDA to collect fees and use them for the process for the review ...